ATC code C09
ATC codes | |||
---|---|---|---|
C Cardiovascular system | |||
C01 Cardiac therapy | |||
C02 Antihypertensives | |||
C03 Diuretics | |||
C04 Peripheral vasodilators | |||
C05 Vasoprotectives | |||
C07 Beta blocking agents | |||
C08 Calcium channel blockers | |||
C09 Agents acting on the renin-angiotensin system | |||
C10 Lipid modifying agents | |||
|
ATC code C09 Agents acting on the renin-angiotensin system is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup C09 is part of the anatomical group C Cardiovascular system.[1]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: QC09...[2]National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
C09A ACE inhibitors, plain
C09AA ACE inhibitors, plain
- C09AA01 Captopril
- C09AA02 Enalapril
- C09AA03 Lisinopril
- C09AA04 Perindopril
- C09AA05 Ramipril
- C09AA06 Quinapril
- C09AA07 Benazepril
- C09AA08 Cilazapril
- C09AA09 Fosinopril
- C09AA10 Trandolapril
- C09AA11 Spirapril
- C09AA12 Delapril
- C09AA13 Moexipril
- C09AA14 Temocapril
- C09AA15 Zofenopril
- C09AA16 Imidapril
C09B ACE inhibitors, combinations
C09BA ACE inhibitors and diuretics
- C09BA01 Captopril and diuretics
- C09BA02 Enalapril and diuretics
- C09BA03 Lisinopril and diuretics
- C09BA04 Perindopril and diuretics
- C09BA05 Ramipril and diuretics
- C09BA06 Quinapril and diuretics
- C09BA07 Benazepril and diuretics
- C09BA08 Cilazapril and diuretics
- C09BA09 Fosinopril and diuretics
- C09BA12 Delapril and diuretics
- C09BA13 Moexipril and diuretics
- C09BA15 Zofenopril and diuretics
C09BB ACE inhibitors and calcium channel blockers
- C09BB02 Enalapril and lercanidipine
- C09BB03 Lisinopril and amlodipine
- C09BB04 Perindopril and amlodipine
- C09BB05 Ramipril and felodipine
- C09BB06 Enalapril and nitrendipine
- C09BB07 Ramipril and amlodipine
- C09BB10 Trandolapril and verapamil
- C09BB12 Delapril and manidipine
C09BX ACE inhibitors, other combinations
- C09BX01 Perindopril, amlodipine and indapamide
- C09BX02 Perindopril and bisoprolol
- QC09BX90 Benazepril and pimobendan
C09C Angiotensin II antagonists, plain
C09CA Angiotensin II antagonists, plain
- C09CA01 Losartan
- C09CA02 Eprosartan
- C09CA03 Valsartan
- C09CA04 Irbesartan
- C09CA05 Tasosartan
- C09CA06 Candesartan
- C09CA07 Telmisartan
- C09CA08 Olmesartan medoxomil
- C09CA09 Azilsartan medoxomil
- C09CA10 Fimasartan
C09D Angiotensin II antagonists, combinations
C09DA Angiotensin II antagonists and diuretics
- C09DA01 Losartan and diuretics
- C09DA02 Eprosartan and diuretics
- C09DA03 Valsartan and diuretics
- C09DA04 Irbesartan and diuretics
- C09DA06 Candesartan and diuretics
- C09DA07 Telmisartan and diuretics
- C09DA08 Olmesartan medoxomil and diuretics
- C09DA09 Azilsartan medoxomil and diuretics
C09DB Angiotensin II antagonists and calcium channel blockers
- C09DB01 Valsartan and amlodipine
- C09DB02 Olmesartan medoxomil and amlodipine
- C09DB04 Telmisartan and amlodipine
- C09DB05 Irbesartan and amlodipine
- C09DB06 Losartan and amlodipine
- C09DB07 Candesartan and amlodipine
- C09DB08 Valsartan and lercanidipine
C09DX Angiotensin II antagonists, other combinations
- C09DX01 Valsartan, amlodipine and hydrochlorothiazide
- C09DX02 Valsartan and aliskiren
- C09DX03 Olmesartan medoxomil, amlodipine and hydrochlorothiazide
- C09DX04 Valsartan and sacubitril
C09X Other agents acting on the renin-angiotensin system
C09XA Renin-inhibitors
- C09XA01 Remikiren
- C09XA02 Aliskiren
- C09XA52 Aliskiren and hydrochlorothiazide
- C09XA53 Aliskiren and amlodipine
- C09XA54 Aliskiren, amlodipine and hydrochlorothiazide
References
- ↑ "ATC/DDD Index 2016: code C09". WHO Collaborating Centre for Drug Statistics Methodology.
- ↑ "ATCvet Index 2016: code QC09". WHO Collaborating Centre for Drug Statistics Methodology.
|
This article is issued from Wikipedia - version of the Monday, January 04, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.